Stockreport

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 (DMRA) 
PDF BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for pati [Read more]